
March 26 (Reuters) - Federal prosecutors in Manhattan are probing a claim brought by GSK GSK.L that Pfizer PFE.N delayed announcing the success of its COVID-19 vaccine in 2020 until after that year's election, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.